The EdU assay and flow cytometry showed that miR-9 increased apoptotic cells and inhibited cell proliferation, all of which may be mediated by the inhibition of eIF5A2, indicating that miR-9 may function as a tumor oncogene in NSCLC cells. The gene discussed is EIF5A2; the disease is neoplasm.